RT Banner 2021V4.gif

China Daily

News> Nation> Content
Sunday, February 28, 2021, 11:37
China conditionally approves one-shot recombinant vaccine
By Xinhua
Sunday, February 28, 2021, 11:37 By Xinhua

In this Jan 11, 2021 photo, a medical worker inoculates a recipient with a COVID-19 vaccine at a temporary inoculation site in Haidian District in Beijing, capital of China. (Xinhua / Ren Chao)

BEIJING - The Chinese National Medical Products Administration granted conditional market approval to a recombinant novel coronavirus vaccine that requires only one shot.

Developed by a research team led by Chen Wei, an academician at the Chinese Academy of Engineering and a researcher at the Institute of Military Medicine under the Academy of Military Sciences, it is China's first approved COVID-19 vaccine that relies on adenovirus as the vector to deliver the coronavirus spike gene into the body.

Targeting people aged above 18, the vaccine can be transported and stored at a temperature ranging from 2 to 8 degrees Celsius

ALSO READ: Mass vaccinations underway in all Beijing districts

Targeting people aged above 18, the vaccine can be transported and stored at a temperature ranging from 2 to 8 degrees Celsius.

The vaccine shows a 65.7-percent efficacy at preventing symptomatic cases and a 90.98-percent efficacy against severe disease in an interim analysis of its global phase-3 clinical trials, according to media reports. In the Pakistan subset, its efficacy at preventing symptomatic cases is 74.8 percent and 100 percent at preventing severe disease. 

READ MORE: China conditionally approves 4 self-developed vaccines

Share this story

CHINA DAILY
HONG KONG NEWS
OPEN
Please click in the upper right corner to open it in your browser !